Ebsteins anomaly of the tricuspid valve causes
|
Ebsteins anomaly of the tricuspid valve Microchapters | |
|
Diagnosis | |
|---|---|
|
Treatment | |
|
Case Studies | |
|
Ebsteins anomaly of the tricuspid valve causes On the Web | |
|
American Roentgen Ray Society Images of Ebsteins anomaly of the tricuspid valve causes | |
|
Risk calculators and risk factors for Ebsteins anomaly of the tricuspid valve causes | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] and Claudia P. Hochberg, M.D. [2]
Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [3]}; Keri Shafer, M.D. [4] Priyamvada Singh, MBBS [[5]] Assistant Editor-In-Chief: Kristin Feeney, B.S. [[6]]
Overview
The genetic or molecular mechanism causing Ebstein's anomaly is largely unknown. However, the incidence is increased in infants born to mothers who have taken lithium during first trimester of pregnancy and those taking benzodiazepines.
Causes
- Lithium ingestion in first trimester of pregnancy.[1][2]
- Benzodiazepine use by the mother.
- Varnishing substances exposure.
References
- ↑ Correa-Villaseñor A, Ferencz C, Neill CA, Wilson PD, Boughman JA (August 1994). "Ebstein's malformation of the tricuspid valve: genetic and environmental factors. The Baltimore-Washington Infant Study Group". Teratology. 50 (2): 137–47. doi:10.1002/tera.1420500208. PMID 7801301.
- ↑ Poels E, Bijma HH, Galbally M, Bergink V (December 2018). "Lithium during pregnancy and after delivery: a review". Int J Bipolar Disord. 6 (1): 26. doi:10.1186/s40345-018-0135-7. PMC 6274637. PMID 30506447. Vancouver style error: initials (help)